Medpace Weakness Means Opportunity
A small-cap healthcare stock with high prospects is Medpace Holdings Inc (NASDAQ:MEDP), a provider of third-party services to the pharmaceutical and medical devices area.
Trading at roughly 23% off its 52-week high of $65.09, the decline in Medpace stock makes for a more reasonable entry point despite being up around 37% this year.
Medpace provides the key Phase I to Phase IV clinical development services to global biotechnology and pharmaceutical companies along with the medical device makers.
In the biotech space, these.
Den vollständigen Artikel lesen ...
A small-cap healthcare stock with high prospects is Medpace Holdings Inc (NASDAQ:MEDP), a provider of third-party services to the pharmaceutical and medical devices area.
Trading at roughly 23% off its 52-week high of $65.09, the decline in Medpace stock makes for a more reasonable entry point despite being up around 37% this year.
Medpace provides the key Phase I to Phase IV clinical development services to global biotechnology and pharmaceutical companies along with the medical device makers.
In the biotech space, these.
Den vollständigen Artikel lesen ...